Showing results (231-240 of 463) with videos related to
Sort By:
Pageof 47
Frontiers in Neurology|July 18, 2024
Dose-response effects of physical exercise standardized volume on peripheral biomarkers, clinical response, and brain connectivity in Parkinson's disease: a prospective, observational, cohort studyRossella Rotondo, Elvira Padua, Giuseppe Annino, et al.Brain : a Journal of Neurology|November 10, 2010
Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's diseaseMaria C Rodriguez-Oroz, Jon López-Azcárate, David Garcia-Garcia, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Lesion of the centromedian thalamic nucleus in MPTP-treated monkeysJose L Lanciego, Maria C Rodríguez-Oroz, Francisco J Blesa, et al.Parkinsonism & Related Disorders|January 30, 2025
Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND studyAaron L Ellenbogen, Werner Poewe, Alberto J Espay, et al.Annals of Medicine|March 5, 2026
Advanced Parkinson's disease treatment patterns in Italy: results from a multicenter observational studyFabrizio Stocchi, Paolo Barone, Roberto Ceravolo, et al.Thescientificworldjournal|February 17, 2015
The "gender factor" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP studyDelia Colombo, Giovanni Abbruzzese, Angelo Antonini, et al.Clinical Pharmacology in Drug Development|July 28, 2022
A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's DiseaseFabrizio Stocchi, Elizabeth L Peckham, Maria Francesca De Pandis, et al.Journal of Neurology|February 13, 2013
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodiesMarco Onofrj, Sara Varanese, Laura Bonanni, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 8, 2009
Validation of the freezing of gait questionnaire in patients with Parkinson's diseaseNir Giladi, Joseph Tal, Tali Azulay, et al.Molecules (Basel, Switzerland)|April 12, 2022
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's DiseaseAkihisa Mori, Jiang-Fan Chen, Shinichi Uchida, et al.Pageof 47